5317 |
Orbital Atherectomy in FP Lesions: Advantages and Limitations |
Michael S. Lee |
Apr. 12. 21 |
5316 |
Non-Atherectomy Strategies for Vessel Preparation in Complex FP Disease |
Hiroshi Ando |
Apr. 12. 21 |
5315 |
Evidence of DCB Treatment for Infrapopliteal Disease |
William A. Gray |
Apr. 12. 21 |
5314 |
DCB Therapy in FP Disease: What\'s the Latest? |
Lawrence A. Garcia |
Apr. 12. 21 |
5313 |
Paclitaxel and Mortality in PAD; The Latest Update |
Thomas Zeller |
Apr. 12. 21 |
5312 |
ECG Changes in Coronary Artery Disease |
Soo Jin Kim |
Apr. 12. 21 |
5311 |
Interpretation of Coronary Angiography |
Euiyoung Ko |
Apr. 12. 21 |
5310 |
What Should We Care About During the MitraClip Procedure? |
Geon-Jae Lee |
Apr. 12. 21 |
5309 |
TAVAR for Bicuspid Valve |
Dong Joon Lee |
Apr. 12. 21 |
5308 |
Optimal Deployment Projection of TAVAR |
Seung Yong Lee |
Apr. 12. 21 |